Pipofezine

This classification denotes an antidepressant agent with the molecular formula C16H19N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P8T739L1FA, chemically known as 5-methyl-3-(4-methyl-1-piperazinyl)-5h-pyridazino(3,4-b)(1,4)benzoxazine but generally known as pipofezine, which bears US NIH Compound Identifier 159977. European Medicines Agency schedules Pipofezine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09877MIG. The term PIPOFEZINE is an International Non-Proprietary Name. PIPOFEZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pipofezine under HS 29349990 and SITC 51579. As of Q4 2014, PIPOFEZINE remains the US FDA Preferred Term for this commodity. Pipofezine bears US NLM identifiers UMLS ID C1882389 and NCI Concept Code C66403. SMILES: O1c2nnc(N3CCN(CC3)C)cc2N(c2c1cccc2)C.